WASHINGTON — Researchers and health care advocates are warning that the debt ceiling deal would mean a harsh cut for science agencies like the National Institutes of Health.
The debt ceiling deal hammered out by the White House and congressional leadership this weekend would freeze non-defense and veterans’ health spending at 2023 levels for next year and allow only a 1% bump in 2025. Individual agencies’ budgets can still rise and fall under this new cap, as long as the total spending number stays at 2023 level.
But that could end up hammering the NIH budget, which has steadily climbed over the years as Congress channeled billions of dollars to research on cancer, Alzheimer’s disease, and rare diseases. The NIH’s overall budget nearly doubled from $25.8 billion in 2003 to $42.9 billion in 2022.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect